Approved NMOSD Therapies 

In 2014, there were 0 FDA-approved therapies for patients living with neuromyelitis optica spectrum disorder (NMOSD). In 2024, there are 4 FDA-approved therapies available for patients living with NMOSD.
In this webinar, Dr. Sean Pittock provided overviews (pharmacology, drug delivery method, dosing, frequency, side effects, reduction in relapse rates, antibody criteria, etc.) of the approved therapies indicated for NMOSD.